DK0948630T3 - Kloning og karakterisering af napsin, en asparaginprotease - Google Patents
Kloning og karakterisering af napsin, en asparaginproteaseInfo
- Publication number
- DK0948630T3 DK0948630T3 DK97948546T DK97948546T DK0948630T3 DK 0948630 T3 DK0948630 T3 DK 0948630T3 DK 97948546 T DK97948546 T DK 97948546T DK 97948546 T DK97948546 T DK 97948546T DK 0948630 T3 DK0948630 T3 DK 0948630T3
- Authority
- DK
- Denmark
- Prior art keywords
- napsin
- enzyme
- protease
- cloned
- expressed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3119696P | 1996-11-20 | 1996-11-20 | |
US4612697P | 1997-05-09 | 1997-05-09 | |
PCT/US1997/021684 WO1998022597A2 (en) | 1996-11-20 | 1997-11-20 | Cloning and characterization of napsin, an aspartic protease |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0948630T3 true DK0948630T3 (da) | 2008-08-11 |
Family
ID=26706937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97948546T DK0948630T3 (da) | 1996-11-20 | 1997-11-20 | Kloning og karakterisering af napsin, en asparaginprotease |
Country Status (11)
Country | Link |
---|---|
US (1) | US6225103B1 (da) |
EP (1) | EP0948630B1 (da) |
JP (2) | JP2001503643A (da) |
AT (1) | ATE393227T1 (da) |
AU (1) | AU734220B2 (da) |
CA (1) | CA2271294A1 (da) |
DE (1) | DE69738653T2 (da) |
DK (1) | DK0948630T3 (da) |
ES (1) | ES2308791T3 (da) |
PT (1) | PT948630E (da) |
WO (1) | WO1998022597A2 (da) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0897986A3 (en) * | 1997-08-21 | 2000-07-05 | Smithkline Beecham Corporation | Aspartic proteinase 5 (ASP5) |
US6203979B1 (en) | 1998-01-16 | 2001-03-20 | Incyte Pharmaceuticals, Inc. | Human protease molecules |
US7045333B1 (en) * | 1998-01-16 | 2006-05-16 | Incyte Corporation | Human protease molecules |
US6432690B1 (en) * | 1998-01-16 | 2002-08-13 | Incyte Genomics, Inc. | Human aspartic proteases |
EP1030911A1 (en) * | 1998-07-16 | 2000-08-30 | Incyte Pharmaceuticals, Inc. | Human aspartic proteases |
EP1939297A1 (en) | 1998-09-24 | 2008-07-02 | Pharmacia & Upjohn Company LLC | Alzheimer's disease secretase |
US7115410B1 (en) * | 1999-02-10 | 2006-10-03 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
US7456007B1 (en) | 1998-12-31 | 2008-11-25 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
NZ534876A (en) | 1999-02-10 | 2006-02-24 | Elan Pharm Inc | Human beta-secretase enzyme, inhibitors and their compositions and uses |
US7514408B1 (en) | 1999-12-02 | 2009-04-07 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
JP2001172200A (ja) * | 1999-12-17 | 2001-06-26 | Meneki Seibutsu Kenkyusho:Kk | ヒトナプシンaに対する抗体およびこれを用いる医薬 |
WO2002000891A2 (en) * | 2000-06-26 | 2002-01-03 | Bayer Aktiengesellschaft | Human napsin-like aspartyl protease |
EP1666452A2 (en) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
EP1500663A1 (en) * | 2000-09-28 | 2005-01-26 | Eli Lilly And Company | Secreted proteins and their uses |
US7217556B1 (en) | 2000-12-23 | 2007-05-15 | Pfizer Inc | Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease |
US7806980B2 (en) * | 2000-12-23 | 2010-10-05 | Elan Pharmaceuticals, Inc. | Method for crystallizing human beta secretase in complex with an inhibitor |
US7601528B1 (en) | 2000-12-23 | 2009-10-13 | Elan Pharmaceuticals, Inc. | Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease |
US7524668B1 (en) * | 2001-05-10 | 2009-04-28 | Elan Pharmaceuticals, Inc. | Crystal of human beta secretase having monoclinic space group symmetry C2 and methods for crystallization thereof |
US7384773B1 (en) * | 2001-05-10 | 2008-06-10 | Pfizer Inc | Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof |
WO2002098849A2 (en) | 2001-06-01 | 2002-12-12 | Elan Pharmaceuticals, Inc. | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases |
JP2004532894A (ja) | 2001-06-13 | 2004-10-28 | イーラン ファーマスーティカルズ、インコーポレイテッド | アルツハイマー病を治療するためのアミンジオール |
US7053109B2 (en) | 2001-07-10 | 2006-05-30 | Pharmacia & Upjohn Company | Aminediols for the treatment of Alzheimer's disease |
WO2003006013A1 (en) | 2001-07-10 | 2003-01-23 | Elan Pharmaceuticals, Inc. | Diaminediols for the treatment of alzheimer's disease |
US7186539B1 (en) | 2001-08-31 | 2007-03-06 | Pharmacia & Upjohn Company | Method for refolding enzymes |
WO2003029169A2 (en) | 2001-10-04 | 2003-04-10 | Elan Pharmaceuticals, Inc. | Hydroxypropylamines |
AU2002359376B2 (en) | 2001-11-08 | 2008-01-10 | Elan Pharmaceuticals, Inc. | N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
DE60327250D1 (de) | 2002-02-21 | 2009-05-28 | Pharmacia & Upjohn Co Llc | Modifizierte bace |
AU2003303141A1 (en) | 2002-04-30 | 2004-07-22 | Elan Pharmaceuticals, Inc. | Hydroxypropyl amides for the treatment of alzheimer's disease |
US7442537B1 (en) | 2002-05-10 | 2008-10-28 | Elan Pharmaceuticals, Inc. | Crystals of unliganded beta secretase and/or beta secretase-like proteins and the use thereof |
WO2004009797A2 (en) * | 2002-07-23 | 2004-01-29 | Incyte Corporation | Protein modification and maintenance molecules |
PE20040762A1 (es) | 2002-11-27 | 2004-11-06 | Elan Pharm Inc | Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer |
TW200512195A (en) | 2003-04-21 | 2005-04-01 | Elan Pharm Inc | Benzamide 2-hydroxy-3-diaminoalkanes |
WO2004099402A1 (en) | 2003-05-02 | 2004-11-18 | Elan Pharmaceuticals, Inc. | Glycosylation variants of bace |
WO2005044977A2 (en) * | 2003-06-25 | 2005-05-19 | Diadexus, Inc. | Compositions, splice variants and methods relating to lung specific genes and proteins |
WO2005087751A2 (en) | 2004-03-09 | 2005-09-22 | Elan Pharmaceuticals, Inc. | Substituted hydroxyethylamine aspartyl protease inhibitors |
WO2005095454A1 (en) * | 2004-03-25 | 2005-10-13 | Diadexus, Inc. | Lng105 antibody composition and methods of use, and use of lng105 to assess lung cancer risk |
CA2573138A1 (en) | 2004-07-09 | 2006-01-26 | Elan Pharmaceuticals Inc. | Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
WO2007047305A1 (en) | 2005-10-12 | 2007-04-26 | Elan Pharmaceuticals, Inc. | Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
EP2164834A2 (en) | 2007-07-06 | 2010-03-24 | Boehringer Ingelheim International GmbH | Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL107250A (en) * | 1993-10-12 | 2001-08-08 | Yeda Res & Dev | Dna molecules involved in programmed cell death, proteins encoded thereby and methods and compositions using said dna molecules and proteins |
GB9618966D0 (en) * | 1996-09-11 | 1996-10-23 | Smithkline Beecham Plc | Novel compounds |
US5776759A (en) * | 1996-09-26 | 1998-07-07 | Incyte Pharmaceuticals, Inc. | Two novel human cathepsin proteins |
-
1997
- 1997-11-20 JP JP52398598A patent/JP2001503643A/ja not_active Withdrawn
- 1997-11-20 AT AT97948546T patent/ATE393227T1/de active
- 1997-11-20 US US08/974,691 patent/US6225103B1/en not_active Expired - Lifetime
- 1997-11-20 DE DE69738653T patent/DE69738653T2/de not_active Expired - Lifetime
- 1997-11-20 EP EP97948546A patent/EP0948630B1/en not_active Expired - Lifetime
- 1997-11-20 AU AU54592/98A patent/AU734220B2/en not_active Ceased
- 1997-11-20 CA CA002271294A patent/CA2271294A1/en not_active Abandoned
- 1997-11-20 PT PT97948546T patent/PT948630E/pt unknown
- 1997-11-20 DK DK97948546T patent/DK0948630T3/da active
- 1997-11-20 WO PCT/US1997/021684 patent/WO1998022597A2/en active IP Right Grant
- 1997-11-20 ES ES97948546T patent/ES2308791T3/es not_active Expired - Lifetime
-
2007
- 2007-11-15 JP JP2007297327A patent/JP2008118996A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU734220B2 (en) | 2001-06-07 |
WO1998022597A3 (en) | 1998-07-09 |
DE69738653D1 (de) | 2008-06-05 |
ES2308791T3 (es) | 2008-12-01 |
PT948630E (pt) | 2008-06-11 |
DE69738653T2 (de) | 2009-06-04 |
EP0948630B1 (en) | 2008-04-23 |
ATE393227T1 (de) | 2008-05-15 |
JP2001503643A (ja) | 2001-03-21 |
EP0948630A2 (en) | 1999-10-13 |
CA2271294A1 (en) | 1998-05-28 |
AU5459298A (en) | 1998-06-10 |
WO1998022597A2 (en) | 1998-05-28 |
US6225103B1 (en) | 2001-05-01 |
JP2008118996A (ja) | 2008-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0948630T3 (da) | Kloning og karakterisering af napsin, en asparaginprotease | |
Collier et al. | H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. | |
Christensson et al. | Complex formation between protein C inhibitor and prostate‐specific antigen in vitro and in human semen | |
Nishiura et al. | The occurrence of an inhibitor of Ca2+-dependent neutral protease in rat liver | |
Shimamoto et al. | Partial characterization of an enzyme fraction with protease activity which converts the spore peptidoglycan hydrolase (SleC) precursor to an active enzyme during germination of Clostridium perfringens S40 spores and analysis of a gene cluster involved in the activity | |
WO1998022597A9 (en) | Cloning and characterization of napsin, an aspartic protease | |
Cao et al. | Identification of a myofibril-bound serine proteinase (MBSP) in the skeletal muscle of lizard fish Saurida wanieso which specifically cleaves the arginine site | |
NO923469L (no) | Chymotrypsin-lignende proteaser og deres inhibitorer | |
Ohara et al. | Cloning, nucleotide sequence, and expression of Achromobacter protease I gene | |
Wei et al. | Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta | |
TAKEDA et al. | Isolation, and catalytic and immunochemical properties of cathepsin D-like acid proteinase from rat erythrocytes | |
Nagano et al. | Molecular cloning and characterization of a serine proteinase gene of Trichinella spiralis | |
Nomura et al. | Sea urchin hatching enzyme (envelysin): cDNA cloning and deprivation of protein substrate specificity by autolytic degradation | |
AU739546B2 (en) | Forms of prostate specific antigen and methods for their detection | |
Yamauchi et al. | Recombinant and native zymogen forms of human complement factor D. | |
Takahashi et al. | Purification and characterization of porcine kidney cathepsin B | |
US4923818A (en) | DNA clone of human type IV collagenase | |
CZ417897A3 (cs) | Lidský žlázový kallikrein-1 (hk2) | |
Herrala et al. | Androgen‐sensitive human prostate cancer cells, LNCaP, produce both N‐terminally mature and truncated prostate‐specific antigen isoforms | |
Olalla et al. | Purification and properties of three proteases from the larvae of the brine shrimp Artemia salina | |
CA1339874C (en) | Dna clone of human type iv collagenase | |
Prescott et al. | [32] Leucostoma peptidase A | |
JP4177253B2 (ja) | 細胞死抑制活性を有するペプチド断片を調製する方法 | |
Mason et al. | Baculoviral expression and characterization of rodent cathepsin S | |
AU2008202374B2 (en) | Genetically modified ecarin and process for producing the same |